
Mikael Lantz
Consultant

Publications
Displaying of publications. Sorted by year, then title.
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
Bushra Shahida, Kleoniki Tsoumani, Tereza Planck, Vijayachitra Modhukur, Pernilla Asp, et al.
(2022) Endocrine, 75 p.856-864
Journal articleLong term outcome after toxic nodular goitre
Gabriel Sjölin, Torquil Watt, Kristina Byström, Jan Calissendorff, Per Karkov Cramon, et al.
(2022) Thyroid Research, 15
Journal articleUse of Thyroid Hormones in Hypothyroid and Euthyroid Patients : A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society
Tereza Planck, Mikael Lantz, Petros Perros, Enrico Papini, Roberto Attanasio, et al.
(2021) Frontiers in Endocrinology, 12
Journal articleSerum CYR61 Levels are Associated with Graves' Ophthalmopathy and Smoking in Patients with Graves' Disease
Perparim Cerri, Bushra Shahida, Mikael Lantz, Tereza Planck
(2021) Hormone and Metabolic Research, 54 p.168-174
Journal articleTreatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient’
Gabriel Sjölin, Kristina Byström, Mats Holmberg, Ove Törring, Selwan Khamisi, et al.
(2021) Endocrinology, Diabetes and Metabolism, 4
Journal articlePrevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
Berglind Jonsdottir, Ida Jönsson, Mikael Lantz
(2019) Endocrine, 64 p.48-54
Journal articleThe Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease
Ola Lindgren, Pernilla Asp, Anna Sundlöv, Jan Tennvall, Bushra Shahida, et al.
(2019) European Thyroid Journal, 8 p.64-69
Journal articleAlterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease
Mahmoud Al Majdoub, Mikael Lantz, Peter Spégel
(2019) Endocrine, 63 p.164-166
Journal articleImpaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism : A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey
Ove Törring, Torquil Watt, Gabriel Sjölin, Kristina Byström, Mirna Abraham-Nordling, et al.
(2019) Thyroid : official journal of the American Thyroid Association, 29 p.322-331
Journal articleSimvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
B. Shahida, P. Sahlstrand Johnson, R. Jain, H. Brorson, P. Åsman, et al.
(2019) Endocrine Connections, 8 p.1230-1239
Journal articleStudy of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population
Bushra Shahida, Tereza Planck, Peter Åsman, Mikael Lantz
(2018) European Thyroid Journal, 7 p.289-293
Journal articleTreatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels
Mahmoud Al-Majdoub, Mikael Lantz, Peter Spégel
(2017) Thyroid : official journal of the American Thyroid Association, 27 p.1109-1117
Journal articleAdjuvant Treatment of Graves' Disease with Diclofenac : Safety, Effects on Ophthalmopathy and Antibody Concentrations
Mikael Lantz, Jan Calissendorff, Frank Träisk, Leif Tallstedt, Tereza Planck, et al.
(2016) European Thyroid Journal, 5 p.6-50
Journal articlePROTEOMICS OF ORBITAL TISSUE IN THYROID-ASSOCIATED ORBITOPATHY.
N Matheis, Mikael Lantz, F H Grus, K A Ponto, D Wolters, et al.
(2015) Journal of Clinical Endocrinology and Metabolism, 100 p.1523-1530
Journal articlePresence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.
Bengt Hallengren, Tereza Planck, Peter Åsman, Mikael Lantz
(2015) European Thyroid Journal, 4 p.197-200
Journal articleASSOCIATION OF BTG2, CYR61, ZFP36, AND SCD GENE POLYMORPHISMS WITH GRAVES' DISEASE AND OPHTHALMOPATHY.
Tereza Planck, Bushra Shahida, Marketa Sjögren, Leif Groop, Bengt Hallengren, et al.
(2014) Thyroid, 24 p.1156-1161
Journal articleIncreased TRAb and/or Low Anti-TPO Titers at Diagnosis of Graves' Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset.
Mikael Lantz, Tereza Planck, Peter Åsman, Bengt Hallengren
(2014) Experimental and Clinical Endocrinology & Diabetes, 122 p.113-117
Journal articleSmoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
Tereza Planck, Bushra Shahida, Hemang Parikh, Kristoffer Ström, Peter Åsman, et al.
(2014) Thyroid, 24 p.1524-1532
Journal articleA cross-sectional study of subclinical and clinical thyroid disorders in women with microscopic colitis compared to controls.
Rita Gustafsson, Bodil Roth, Mikael Lantz, Bengt Hallengren, Jonas Manjer, et al.
(2013) Scandinavian Journal of Gastroenterology, 48 p.1414-1422
Journal articleHypertyreos inducerad av jodkontrastmedel är svårbehandlad. Kan leda till fördröjd terapi av tumörsjukdom, visar två fall.
Helene Nilsson, Bengt Hallengren, Mikael Lantz
(2013) Läkartidningen, 110 p.1470-1472
Journal articleIntraorbital deiodinase type 2 expression is downregulated in chronic phase of Graves' ophthalmopathy.
Tereza Planck, Hemang Parikh, Leif Groop, Bengt Hallengren, Mikael Lantz
(2012) Clinical Endocrinology, 77 p.487-488
Journal article (letter)Antibodies to Citrullinated Protein Antigen (ACPA) are Not Biomarkers for Grave'S Ophalmopathy.
Jan Calissendorf, Mikael Lantz, Sergiu-Bogdan Catrina
(2012) Clinical Endocrinology, 77 p.329-329
Journal article (letter)Maternal Autoimmune Thyroid Disease and the Fetal Immune System.
J Svensson, C Oderup, Christina Silver, K Uvebrant, Bengt Hallengren, et al.
(2011) Experimental and Clinical Endocrinology & Diabetes, 119 p.445-450
Journal articleIncidence of hyperthyroidism in Sweden
Mirna Abraham-Nordling, Kristina Bystrom, Ove Torring, Mikael Lantz, Gertrud Berg, et al.
(2011) European Journal of Endocrinology, 165 p.899-905
Journal articleGene Expression in Graves' Ophthalmopathy and Arm Lymphedema: Similarities and Differences.
Tereza Planck, Hemang Parikh, Håkan Brorson, Tuve Mårtensson, Peter Åsman, et al.
(2011) Thyroid, 21 p.663-674
Journal articleThyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine
Mirna Abraham-Nordling, Goran Wallin, Frank Traisk, Gertrud Berg, Jan Calissendorff, et al.
(2010) European Journal of Endocrinology, 163 p.651-657
Journal articlePregnant Women on Thyroxine Substitution Are Often Dysregulated in Early Pregnancy.
Bengt Hallengren, Mikael Lantz, Bengt Andréasson, Lars Grennert
(2009) Thyroid, 19 p.391-394
Journal articleThyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131.
Frank Träisk, Leif Tallstedt, Mirna Abraham-Nordling, Tommy Andersson, Gertrud Berg, et al.
(2009) The Journal of clinical endocrinology and metabolism, 94 p.3700-3707
Journal articleImmigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma
Mikael Lantz, Mirna Abraham-Nordling, Johan Svensson, Goeran Wallin, Bengt Hallengren
(2009) European Journal of Endocrinology, 160 p.201-206
Journal articleIncidence of hyperthyroidism in Stockholm, Sweden, 2003-2005
Mirna Abraham-Nordling, Ove Törring, Mikael Lantz, Bengt Hallengren, Hans Ohrling, et al.
(2008) European Journal of Endocrinology, 158 p.823-827
Journal articleThyrostimulin (a TSH-like Hormone) Expression in Orbital and Thyroid Tissue.
Mikael Lantz, Tereza Planck, Annika Capretz, Emma Nilsson, Christofer Frenander, et al.
(2007) Thyroid, 17 p.113-118
Journal articleCOX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy
Tereza Planck, Annika de Capretz, Hemang Parikh, Christofer Frenander, Peter Åsman, et al.
(2007) Thyroid, 17 p.511-517
Journal articleTreatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.
Mozhgan Dorkhan, Mikael Lantz, Anders Frid, Leif Groop, Bengt Hallengren
(2006) Clinical Endocrinology, 65 p.35-39
Journal articleOverexpression of immediate early genes in active Graves' ophthalmopathy.
Mikael Lantz, Tereza Planck, Hemang Parikh, Christofer Frenander, Martin Ridderstråle, et al.
(2005) Journal of Clinical Endocrinology and Metabolism, 90 p.4784-4791
Journal articleThe biosynthesis of neutrophil and eosinophil granule proteins
Inge Olsson, Arne Egesten, Urban Gullberg, Mikael Lantz, K Stromberg, et al.
(1986) Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society, 24 p.89-97
Journal article